YNR068C Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YNR068C antibody; N3551Uncharacterized protein YNR068C antibody
Target Names
YNR068C
Uniprot No.

Q&A

What is YNR068C Antibody and what are its target specifications?

YNR068C Antibody is a rabbit polyclonal antibody that specifically recognizes the uncharacterized YNR068C protein in Saccharomyces cerevisiae (Baker's yeast), particularly in strain 204508/S288c. The antibody targets a protein with a molecular weight of approximately 31,219 Da and is generated using recombinant Saccharomyces cerevisiae as the immunogen. The antibody undergoes antigen-affinity purification to ensure specificity and is designated for research use only, not for diagnostic procedures .

When designing experiments with this antibody, it's important to consider that as a polyclonal antibody, it likely recognizes multiple epitopes on the target protein, which may provide stronger signal detection but could potentially introduce cross-reactivity concerns that need validation. The recombinant nature of the immunogen suggests the antibody may preferentially recognize properly folded protein conformations.

What are the formulation characteristics and storage requirements for optimal YNR068C Antibody performance?

The YNR068C Antibody is supplied in liquid format with a specific formulation that includes 0.03% Proclin 300 as a preservative, 50% glycerol, and 0.01M PBS at pH 7.4 . This formulation is designed to maintain antibody stability and activity during storage and handling procedures.

For optimal performance, the antibody should be stored at -20°C for long-term stability, with aliquoting recommended upon receipt to minimize freeze-thaw cycles that can compromise antibody function. When preparing to use the antibody, it should be thawed completely and equilibrated to room temperature, then mixed gently by tube inversion rather than vortexing, which can damage the antibody structure. Working dilutions should be prepared fresh for each experiment and should not be stored for extended periods.

What validation methods should be employed to verify YNR068C Antibody specificity?

A comprehensive validation strategy for YNR068C Antibody should include multiple complementary approaches:

  • Western blot analysis comparing wild-type yeast with a YNR068C knockout strain to confirm antibody specificity

  • Immunoprecipitation followed by mass spectrometry to identify all proteins recognized by the antibody

  • Competitive blocking experiments using recombinant YNR068C protein to demonstrate specific binding

  • Cross-strain validation to assess recognition consistency across different S. cerevisiae strains

  • Epitope mapping to characterize binding regions, particularly if protein domains have specific functions

Each validation step should be meticulously documented with detailed experimental conditions. For Western blot validation, protein samples should be prepared using standardized extraction methods, with equal loading confirmed by total protein staining rather than relying solely on housekeeping proteins that may vary across conditions.

How should immunoprecipitation protocols be optimized for YNR068C antibody in yeast systems?

Optimizing immunoprecipitation (IP) with YNR068C Antibody requires systematic modification of multiple parameters to achieve maximum specificity and yield:

Recommended IP Protocol Framework:

  • Cell lysis optimization:

    • Test multiple lysis methods (mechanical disruption with glass beads vs. enzymatic spheroplasting)

    • Compare buffer compositions varying in:

      • Salt concentration (150-400 mM NaCl)

      • Detergent type and concentration (0.5-1% NP-40, 0.1-0.5% Triton X-100)

      • pH range (7.0-8.0)

    • Always include fresh protease and phosphatase inhibitor cocktails

  • Antibody binding parameters:

    • Optimize antibody concentration (2-10 μg per 500 μg total protein)

    • Test incubation time (2 hours vs. overnight at 4°C)

    • Compare direct addition vs. pre-binding to beads

  • Washing stringency balance:

    • Develop a washing strategy that removes non-specific interactions while preserving specific binding

    • Test increasing salt concentrations (150-500 mM NaCl)

    • Evaluate detergent concentration effect (0.1-1%)

    • Compare number of washes (3-6 washes)

For each optimization step, analyze results by Western blotting for both the target protein and potential contaminants, documenting all parameters systematically for reproducibility.

What approaches enable accurate quantification of YNR068C protein expression levels?

For reliable quantification of YNR068C protein, researchers should consider these methodological approaches:

Western Blot Quantification Protocol:

  • Standard curve development:

    • Prepare a dilution series (5-7 points) of recombinant YNR068C protein

    • Load alongside experimental samples

    • Process all samples identically for antibody incubation and detection

    • Generate calibration curve of signal intensity vs. protein amount

  • Sample preparation controls:

    • Extract proteins using denaturing conditions (SDS extraction)

    • Quantify total protein using bicinchoninic acid (BCA) or Bradford assay

    • Load equal protein amounts (20-40 μg per lane)

    • Include technical replicates for statistical validation

  • Detection system considerations:

    • Use digital imaging systems rather than film for wider linear range

    • Avoid saturated signals which prevent accurate quantification

    • Apply background subtraction consistently across all samples

  • Normalization approach:

    • Use total protein normalization via stain-free technology or Ponceau staining

    • If using loading controls, validate their stability under your experimental conditions

    • Calculate target/reference ratio for each sample

For each quantification experiment, document exposure settings, image acquisition parameters, and quantification boundaries to ensure reproducibility across experiments.

How can YNR068C Antibody be effectively employed in immunofluorescence microscopy for yeast cells?

Successful immunofluorescence with YNR068C Antibody in yeast requires optimizing multiple steps:

Yeast Immunofluorescence Protocol Framework:

  • Cell wall permeabilization strategies:

    • Test enzymatic digestion with zymolyase (0.1-1 mg/ml, 30-60 minutes)

    • Compare with DTT pretreatment followed by mild detergent permeabilization

    • Evaluate effect of fixative type on antibody accessibility (formaldehyde vs. methanol)

  • Fixation optimization:

    • Compare 4% paraformaldehyde (10-30 minutes) vs. methanol fixation (-20°C, 6-10 minutes)

    • Assess impact of fixation time on epitope preservation

    • Consider post-fixation quenching with glycine or sodium borohydride to reduce autofluorescence

  • Blocking and antibody incubation:

    • Test blocking solutions (3-5% BSA, 5-10% normal serum)

    • Optimize primary antibody dilution (starting range: 1:100-1:500)

    • Compare incubation times (1 hour at room temperature vs. overnight at 4°C)

    • Select appropriate secondary antibody with minimal cross-reactivity to yeast proteins

  • Controls for specificity:

    • YNR068C knockout strain as negative control

    • GFP-tagged YNR068C strain for colocalization validation

    • Secondary antibody-only samples to assess background

Systematic documentation of each parameter is essential for reproducibility across experiments and different yeast strains.

What methodological approaches enable reliable co-immunoprecipitation studies to identify YNR068C protein interaction partners?

For discovering YNR068C protein interaction partners, implement this systematic co-immunoprecipitation approach:

Co-IP Optimization Strategy:

  • Buffer composition tailoring:

    • Test mild non-ionic detergents (0.1-0.5% NP-40 or Triton X-100)

    • Optimize salt concentration to preserve interactions (100-200 mM NaCl)

    • Include stabilizing agents (5-10% glycerol) to maintain complex integrity

    • Add reversible cross-linkers for transient interactions (DSP, 0.5-2 mM)

  • Experimental controls implementation:

    • "Bead-only" control to identify non-specific binders

    • IgG isotype control to account for antibody-related background

    • YNR068C knockout strain as negative control

    • Reciprocal Co-IP with antibodies against suspected partners

  • Sample preparation technique:

    • Gentle cell lysis to preserve protein complexes

    • Pre-clearing lysate with beads to reduce background

    • Stepwise washing gradient to identify stable vs. transient interactors

    • Native elution vs. denaturing elution comparison

  • Interaction validation approach:

    • Mass spectrometry identification of co-precipitating proteins

    • Filtering against CRAPome database to remove common contaminants

    • Confirmation by reciprocal Co-IP for selected candidates

    • Secondary validation by proximity labeling or yeast two-hybrid

Document interaction strength through quantitative analysis of pull-down efficiency, comparing protein abundance in input vs. immunoprecipitated fractions.

How should researchers approach chromatin immunoprecipitation (ChIP) experiments with YNR068C Antibody?

Adapting YNR068C Antibody for chromatin immunoprecipitation requires specific methodological considerations:

ChIP Protocol Optimization Framework:

  • Cross-linking parametrization:

    • Test formaldehyde concentration range (0.5-3%)

    • Optimize cross-linking time (10-30 minutes)

    • Consider dual cross-linking with disuccinimidyl glutarate (DSG) for improved efficiency

    • Verify cross-linking efficiency by examining protein-DNA complexes on SDS-PAGE

  • Chromatin fragmentation strategy:

    • Optimize sonication parameters specifically for yeast cells

    • Target fragment size of 200-500 bp for high resolution

    • Verify fragmentation by agarose gel electrophoresis

    • Consider enzymatic fragmentation alternatives (MNase digestion)

  • Antibody validation for ChIP:

    • Test antibody specificity under ChIP conditions

    • Compare enrichment between wild-type and YNR068C knockout strains

    • Determine optimal antibody amount (2-5 μg per reaction)

    • Include mock IP controls (no antibody, isotype control)

  • Data analysis considerations:

    • Normalize to input DNA for each primer set

    • Include non-target genomic regions as negative controls

    • Apply appropriate statistical analysis for replicate experiments

    • For ChIP-seq, implement peak calling with suitable algorithms for yeast genome

This systematic approach enables reliable identification of YNR068C chromatin interactions while minimizing false positives from non-specific binding.

What strategies enable effective troubleshooting of non-specific binding with YNR068C Antibody?

When encountering non-specific binding with YNR068C Antibody, implement this systematic troubleshooting framework:

Western Blot Non-Specific Binding Troubleshooting:

ParameterStandard ConditionModification 1Modification 2Modification 3
Blocking5% milk in TBST, 1h RT5% BSA in TBST, 1h RTCommercial blocker, 1h RT5% milk, overnight 4°C
Antibody dilution1:1000 in TBST1:2000 in TBST1:1000 in TBST + 0.1% SDS1:1000 in 5% milk
Wash stringency3x5 min TBST5x5 min TBST3x10 min TBST3x5 min high-salt TBST
Sample amount50 μg protein25 μg protein10 μg protein5 μg protein

Immunoprecipitation Non-Specific Binding Remediation:

  • Pre-clear lysates thoroughly:

    • Extend pre-clearing time with Protein A/G beads (1-2 hours)

    • Add non-immune serum from the same species as the antibody

    • Use higher bead volume for pre-clearing (50-100 μl per ml lysate)

  • Optimize washing conditions:

    • Implement stepped washing with increasing salt concentration

    • Add low concentrations of competing detergents (0.1-0.5% SDS)

    • Increase wash volume and number of washes

    • Consider wash additives like 1-5% Triton X-100 to reduce hydrophobic interactions

  • Bead selection optimization:

    • Compare different bead types (agarose vs. magnetic)

    • Test various Protein A/G formulations based on antibody subclass

    • Consider covalent antibody coupling to eliminate antibody bands

Implement changes systematically, testing one modification at a time while keeping all other variables constant, and document outcomes comprehensively.

How can YNR068C Antibody be utilized to examine protein dynamics across cell cycle phases?

For investigating YNR068C dynamics throughout the cell cycle, implement this comprehensive methodological approach:

Cell Cycle Analysis Protocol:

  • Synchronization method selection:

    • Compare α-factor arrest (G1 phase), hydroxyurea block (S phase), and nocodazole treatment (G2/M phase)

    • Validate synchronization by flow cytometry with propidium iodide staining

    • Assess synchronization impact on YNR068C expression independently of cell cycle effects

  • Time-course experimental design:

    • Collect samples at precise intervals following release from synchronization

    • Process all samples identically for protein extraction and analysis

    • Quantify YNR068C levels alongside established cell cycle markers (Clb2, Sic1)

    • Document cell cycle progression via budding index and DNA content analysis

  • Microscopy-based approach:

    • Perform immunofluorescence at defined cell cycle points

    • Co-stain with DAPI for DNA visualization

    • Categorize cells based on morphology and nuclear positioning

    • Apply quantitative image analysis for protein abundance and localization

  • Data analysis framework:

    • Plot YNR068C levels against time post-release

    • Normalize to cell-cycle independent proteins

    • Apply appropriate statistical tests for cyclic data

    • Create comprehensive visualization showing protein dynamics across all cell cycle phases

This systematic approach enables distinction between genuine cell-cycle regulation and artifacts of synchronization methods.

What considerations are important when studying YNR068C localization changes under stress conditions?

To effectively examine YNR068C localization dynamics under stress, implement this methodological framework:

Stress Response Protocol Design:

  • Stress condition standardization:

    • Define precise stress parameters (temperature, duration, concentration)

    • Apply consistent stress application methods across experiments

    • Include recovery time points to assess reversibility

    • Validate stress responses using known markers (e.g., Msn2/4 nuclear translocation)

  • Microscopy approach adaptation:

    • Utilize live-cell imaging when possible to track dynamic changes

    • Implement rapid fixation methods to capture transient states

    • Consider photobleaching techniques to distinguish new synthesis from redistribution

    • Employ consistent exposure parameters for quantitative comparisons

  • Co-localization analysis:

    • Include markers for specific compartments (nucleus, ER, Golgi, vacuole, mitochondria)

    • Apply appropriate co-localization statistics (Pearson's, Manders' coefficients)

    • Use structured illumination or confocal microscopy for improved resolution

    • Develop clear criteria for scoring localization patterns

  • Quantification strategy:

    • Measure intensity ratios between compartments

    • Track protein redistribution kinetics

    • Analyze changes in aggregate/puncta formation

    • Apply automated image analysis for unbiased assessment

This approach enables reliable detection of conditional localization changes while distinguishing specific responses from general cellular disruption.

What statistical approaches are appropriate for analyzing quantitative data generated with YNR068C Antibody?

For robust statistical analysis of YNR068C Antibody-generated data, implement these methodological approaches:

Statistical Framework Based on Experiment Type:

  • Western blot quantification:

    • Verify normal distribution of data (Shapiro-Wilk test)

    • For normally distributed data: paired t-test (two conditions) or one-way ANOVA with post-hoc tests (multiple conditions)

    • For non-normally distributed data: Wilcoxon signed-rank test or Kruskal-Wallis with post-hoc tests

    • Report effect sizes along with p-values

    • Present data with individual points, mean/median, and appropriate error bars

  • Immunofluorescence intensity analysis:

    • Account for cellular heterogeneity through adequate sample size (>50 cells per condition)

    • Consider hierarchical statistical approaches (cells nested within experiments)

    • Apply appropriate transformations for non-normally distributed intensity data

    • Control for multiple comparisons with Bonferroni or Benjamini-Hochberg corrections

  • Colocalization analysis:

    • Select appropriate coefficients (Pearson's for linear relationships, Manders' for overlap)

    • Apply Fisher's z-transformation for comparing correlation coefficients

    • Utilize randomization tests to establish significance thresholds

    • Consider object-based approaches for punctate distributions

  • Time-course experiments:

    • Apply repeated measures ANOVA for continuous measurements

    • Consider time series analysis for cyclic patterns

    • Use area under curve calculations for cumulative effects

    • Implement mixed models to account for missing data points

For all statistical approaches, document software packages, statistical tests, significance thresholds, and any data transformations applied.

How should contradictory results between different detection methods for YNR068C be reconciled?

When facing discrepancies between different methods of YNR068C detection, implement this systematic reconciliation approach:

Methodological Reconciliation Framework:

  • Technical validation analysis:

    • Verify antibody performance in each method separately

    • Confirm positive and negative controls work appropriately in each system

    • Assess whether detection sensitivity differs between methods

    • Examine whether sample preparation might affect epitope accessibility

  • Biological interpretation considerations:

    • Evaluate if discrepancies reflect different protein pools or conformations

    • Consider post-translational modifications that might affect antibody recognition

    • Assess potential for protein complex formation masking epitopes

    • Examine if cellular compartmentalization might explain differences

  • Reconciliation experimental design:

    • Implement orthogonal detection methods (e.g., epitope tagging)

    • Use multiple antibodies targeting different epitopes

    • Apply genetic approaches (knockout/knockdown) for validation

    • Design experiments specifically addressing the source of discrepancy

  • Documentation and reporting:

    • Clearly describe discrepancies rather than selectively reporting concordant results

    • Present side-by-side comparisons with standardized samples

    • Discuss limitations of each method objectively

    • Propose biological or technical explanations for differences

This systematic approach transforms apparent contradictions into deeper insights about YNR068C biology and methodological limitations.

How might YNR068C Antibody be integrated with emerging technologies for comprehensive protein characterization?

YNR068C Antibody can be leveraged with cutting-edge technologies to achieve deeper protein characterization:

Advanced Technology Integration Strategies:

  • Proximity labeling applications:

    • Combine with BioID or APEX2 systems to map protein interaction networks

    • Identify transient interactions that traditional co-IP might miss

    • Characterize spatial organization of YNR068C in specific cellular compartments

    • Compare interaction profiles under different physiological conditions

  • Single-cell analysis approaches:

    • Adapt for mass cytometry (CyTOF) with metal-conjugated antibodies

    • Implement in microfluidic platforms for studying cell-to-cell variability

    • Combine with single-cell transcriptomics for multi-omics correlation

    • Develop flow cytometry protocols for measuring YNR068C in individual yeast cells

  • Advanced microscopy integration:

    • Optimize for super-resolution techniques (STORM, PALM, STED)

    • Implement live-cell nanobody derivatives for dynamic studies

    • Apply correlative light and electron microscopy (CLEM) for ultrastructural context

    • Utilize lattice light-sheet microscopy for 3D dynamics with reduced phototoxicity

  • Computational biology approaches:

    • Integrate antibody-derived localization data with protein structure predictions

    • Apply machine learning for pattern recognition in complex YNR068C datasets

    • Develop systems biology models incorporating YNR068C function

    • Create predictive models of protein behavior under various conditions

These integration strategies position YNR068C research at the cutting edge of yeast molecular biology while maximizing the utility of existing antibody resources.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.